Purdue Honors Biomet Co-Founder

Posted: Updated:
Miller co-founded Biomet Inc. in 1977. Miller co-founded Biomet Inc. in 1977.

Purdue University will name the headship of the Weldon School of Biomedical Engineering after the late Dane Miller, a co-founder and former chief executive officer of Biomet Inc. The move is the result of a gift from Miller's wife, Mary Louise Miller.

The amount of the gift was not disclosed. Dane Miller founded Biomet, now known as Zimmer Biomet Holdings Inc. (NYSE: ZBH), in 1977. The company became a $2 billion enterprise before being acquired by Zimmer Holdings Inc. in a $13 billion deal last year. 

"Dane Miller was one of the greatest engineers and job-creators our nation has known. And one of the great human beings – unpretentious, unaffected, kind to all around him," said Purdue President Mitch Daniels. "Purdue is honored to be associated with his name and memory."

George Wodicka, the founding head of the Weldon School of Biomedical Engineering, will assume the title of Dane A. Miller Head of Biomedical Engineering. He says Biomet's partnerships with the Weldon School helped the biomedical engineering program grow.

"There was a natural resonance between Biomet and our educational and research programs," said Wodicka. "Dane’s support helped make biomedical engineering at Purdue an industry-ready program, which is one of our strengths. For this world-renowned leader in orthopedics, and friend of Purdue, to be forever associated with the Weldon School through this named headship is a tremendous honor for us." 

Dane Miller passed away in February 2015. Mary Louise Miller said using the gift to empower the Weldon School and enable future advances in biomedical engineering is a "very fitting tribute" to her late husband's memory.

  • Perspectives

    • Circling Back on WeWork

      Back in July when we first discussed WeWork, this fast-growing but money-losing venture was one of the most talked-about IPOs in years. At that time, we noted that it was too early to say what would happen, but “it should be very interesting to watch it all play out.” Turns out, that was a massive understatement!



  • Most Popular Stories

    • Photo courtesy of MutualBank

      MutualBank President Dies

      The President and Chief Operating Officer of Muncie-based MutalBank Pat Botts has died. In a statement on Facebook posted Sunday, the company said the passing was unexpected.

    • Artist rendering of proposed headquarters for Ruoff Home Mortgage in Fort Wayne.

      Ruoff to Build New HQ in Downtown Fort Wayne

      Fort Wayne-based Ruoff Home Mortgage has announced plans to build a $43 million corporate headquarters in downtown Fort Wayne. Plans call for a 110-thousand square foot, nine-story structure, at the corner of Ewing Street and Jefferson Boulevard. The building would include leasable office and retail space, as well as a parking garage. It would overlook Parkview Field, home of the Fort Wayne Tin Caps minor league baseball team. The company is currently located on...

    • Photo courtesy of Indiana Premium outlets

      Simon Announces New Name for Shopping Center

      Indianapolis-based Simon Property Group Inc. (NYSE: SPG) has announced Edinburgh Premium Outlets will become Indiana Premium Outlets. The company says extensive enhancements are currently underway to reflect the new name and are slated for completion by Holiday 2019. 

    • (image provided by Purdue University)

      'PlaneEnglish' Technology Lands U.S. Air Force Funding

      Technology intended to help young pilots learn how to better communicate with air traffic controllers has caught the attention of the United States Air Force and earned the two Purdue University graduates, who developed the software, a $50,000 federal grant. The creators of the simulator technology PlaneEnglish have been awarded a Small Business Innovation Research award. 

    • FDA Approves Lilly Migraine Drug

      The U.S. Food and Drug Administration has given another approval for a drug from Indianapolis-based Eli Lilly and Co. (NYSE: LLY). The approval of REYVOW is for the treatment of patients with acute migraines.